Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.

about

Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities.

P2860

Q40175191-1C20CBDB-2DD6-4E1C-B038-FCA82EDA3AC0

P2860

Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.

Item

http://www.wikidata.org/entity/Q38849466

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.

@en

type

Item

label

Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.

@en

prefLabel

Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.

@en

P1476

Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.

@en

P2093

Gail E Reid

http://www.w3.org/2001/XMLSchema#string

Justin T Seroy

http://www.w3.org/2001/XMLSchema#string

Shellee A Grim

http://www.w3.org/2001/XMLSchema#string

Trevor Wellington

http://www.w3.org/2001/XMLSchema#string

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

Susceptibility of urinary tract bacteria to fosfomycin

In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.

Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review.

Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli

The mechanism of action of fosfomycin (phosphonomycin).

The epidemiology of urinary tract infection.

The fosfomycin resistance gene fosB3 is located on a transferable, extrachromosomal circular intermediate in clinical Enterococcus faecium isolates.

Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms.

P304

2563-2568

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKW178

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nina Clark

P577

2016-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27246234

http://www.w3.org/2001/XMLSchema#string

Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.

about

P2860

P2860

Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698